Referred to the House Committee on Veterans' Affairs.
This bill, the Veterans with ALS Reporting Act, requires the Secretary of Veterans Affairs (VA), in consultation with the Director of the Centers for Disease Control and Prevention (CDC), to produce a report to Congress within one year assessing the incidence and prevalence of amyotrophic lateral sclerosis (ALS) in veterans. The report must describe existing VA and CDC resources and supports for veterans with ALS, identify deficiencies, propose strategies to develop and test risk-reduction measures, outline ways to enable VA patients to participate in VA-sponsored clinical trials and research, and offer legislative recommendations.
Scope of federal action: liberals expect the report to lead to funded programs; conservatives emphasize avoiding unfunded mandates or entitlements.
Relative to its intended legislative type, this bill is a well-scoped reporting requirement that clearly assigns responsibility, deadlines, consultation, and specific report content, and it integrates with existing statutory definitions and the CDC ALS registry.
This bill, the Veterans with ALS Reporting Act, requires the Secretary of Veterans Affairs (VA), in consultation with the Director of the Centers for Disease Control and Prevention (CDC), to produce a report to Congress within one year assessing the incidence and prevalence of amyotrophic lateral sclerosis (ALS) in veterans.
The report must describe existing VA and CDC resources and supports for veterans with ALS, identify deficiencies, propose strategies to develop and test risk-reduction measures, outline ways to enable VA patients to participate in VA-sponsored clinical trials and research, and offer legislative recommendations.
The VA must track ALS prevalence in veterans using the CDC ALS registry and biorepository and provide updates to Congress three years after enactment and every three years thereafter.
On content alone, the bill is narrow, technical, and addresses veteran health surveillance and research — areas that commonly attract bipartisan support. It does not create major fiscal or regulatory commitments, which lowers opposition. The principal hurdles are procedural (committee scheduling, potential overlaps with existing agency work) rather than substantive.
Relative to its intended legislative type, this bill is a well-scoped reporting requirement that clearly assigns responsibility, deadlines, consultation, and specific report content, and it integrates with existing statutory definitions and the CDC ALS registry.
Scope of federal action: liberals expect the report to lead to funded programs; conservatives emphasize avoiding unfunded mandates or entitlements.
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope of federal action: liberals expect the report to lead to funded programs; conservatives emphasize avoiding unfunded mandates or entitlements.
A mainstream progressive would likely view the bill positively as a targeted, evidence-focused step to address a serious neurological disease affecting veterans.
They would appreciate the emphasis on incidence/prevalence assessment, use of the CDC registry, and a requirement for strategies to reduce risk and expand clinical trial access for veterans.
However, they may be concerned that the bill only requires a report and tracking without dedicated funding or firm commitments to implement recommended interventions.
A pragmatic moderate would likely support the bill as a narrow, oversight-oriented step to better understand ALS among veterans while demanding clarity on costs and implementation.
They would see value in interagency collaboration (VA and CDC) and in tracking through an established registry, but would want assurance that the reporting requirement is actionable and not merely symbolic.
Centrists would emphasize the need for clear metrics, timelines, and identification of any resource needs so Congress can evaluate whether to fund follow-up actions.
A mainstream conservative would likely be generally favorable to a narrowly tailored bill that focuses on veterans' health and data collection, while remaining attentive to concerns about federal overreach, costs, and privacy.
They would welcome efforts to help veterans and to improve knowledge about ALS, but may push back on any subsequent proposals that expand VA authority, create new entitlements, or require substantial new spending without offsets.
Conservatives may also ask for safeguards around data sharing and for clear justification that the reporting requirement is not duplicative of existing VA or CDC work.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is narrow, technical, and addresses veteran health surveillance and research — areas that commonly attract bipartisan support. It does not create major fiscal or regulatory commitments, which lowers opposition. The principal hurdles are procedural (committee scheduling, potential overlaps with existing agency work) rather than substantive.
The bill has not accumulated any surfaced votes yet.
Scope of federal action: liberals expect the report to lead to funded programs; conservatives emphasize avoiding unfunded mandates or entit…
On content alone, the bill is narrow, technical, and addresses veteran health surveillance and research — areas that commonly attract bipar…
Relative to its intended legislative type, this bill is a well-scoped reporting requirement that clearly assigns responsibility, deadlines, consultation, and specific report content, and it integrates with existing stat…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.